Actym Therapeutics

Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies. Actym is also developing a broad pipeline of additional therapeutic candidates intended to treat checkpoint refractory histologies across the solid tumor spectrum through DNA, mRNA, and protein delivery.